Kantonsspital St.Gallen
login

publications

Paul Martin Putora

title  
 
Zeitlberger A, Putora P M, Hofer S, Schucht P, Migliorini D, Hottinger A F, Roelcke U, Läubli H, Spina P, Bozinov O, Weller M, Neidert M C, Hundsberger T. Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis. J Neurooncol 2022;.
   
Fischer G F, Brügge D, Andratschke N, Baumert B G, Bosetti D G, Caparrotti F, Herrmann E, Papachristofilou A, Rogers S, Schwyzer L, Zwahlen D R, Hundsberger T, Putora P M. Postoperative radiotherapy for meningiomas - a decision-making analysis. BMC Cancer 2022; 22:492.
   
Koechli C, Vu E, Sager P, Näf L, Fischer T, Putora P M, Ehret F, Fürweger C, Schröder C, Förster R, Zwahlen D R, Muacevic A, Windisch P. Convolutional Neural Networks to Detect Vestibular Schwannomas on Single MRI Slices: A Feasibility Study. Cancers (Basel) 2022; 14:.
   
Aeppli S, Schmaus M, Eisen T, Escudier B, Grünwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B I, Schmidinger M, Sternberg C N, Rothermundt C, Putora P M. First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts. ESMO Open 2021; 6:100030.
   
Sager P, Näf L, Vu E, Fischer T, Putora P M, Ehret F, Fürweger C, Schröder C, Förster R, Zwahlen D R, Muacevic A, Windisch P. Convolutional Neural Networks for Classifying Laterality of Vestibular Schwannomas on Single MRI Slices-A Feasibility Study. Diagnostics (Basel) 2021; 11:.
   
Achard V, Panje C, Engeler D, Zilli T, Putora P M. Localized and Locally Advanced Prostate Cancer: Treatment Options. Oncology 2021; 99:413-421.
   
Dennstädt F, Treffers T, Iseli T, Panje C, Putora P M. Creation of clinical algorithms for decision-making in oncology: an example with dose prescription in radiation oncology. BMC Med Inform Decis Mak 2021; 21:212.
   
Ukegjini K, Putora P M, Guidi M, Süveg K, Cihoric N, Widmann B, Steffen T. Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases. Oncology 2021; 99:601-610.
   
Glatzer M, Leskow P, Caparrotti F, Elicin O, Furrer M, Gambazzi F, Dutly A, Gelpke H, Guckenberger M, Heuberger J, Inderbitzi R, Cafarotti S, Karenovics W, Kestenholz P, Kocher G J, Kraxner P, Krueger T, Martucci F, Oehler C, Ozsahin M, Papachristofilou A, Wagnetz D, Zaugg K, Zwahlen D, Opitz I, Putora P M. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. Transl Lung Cancer Res 2021; 10:1960-1968.
   
Fischer T, El Baz Y, Wildermuth S, Leschka S, Guesewell S, Putora P M, Dietrich T. Retrospective evaluation of routine in-hospital observation in 433 patients after CT-guided biopsies. Acta Radiol 2021;2841851211011564.
   
Forrer F, Fischer G, Maas O, Giovanella L, Hoffmann M, Iakovou I, Luster M, Mihailovic J, Petranovic Ovčaričekj P, Vrachimis A, Zerdoud S, Putora P M. Variations in Radioiodine Therapy in Europe - Decision-Making after Total Thyroidectomy. Oncology 2021;.
   
Süveg K, Le Pechoux C, Faivre-Finn C, Putora P M, De Ruysscher D, Widder J, Van Houtte P, Troost E G C, Slotman B J, Ramella S, Pöttgen C, Peeters S T H, Nestle U, McDonald F, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Glatzer M. Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART. Clin Lung Cancer 2021; 22:579-586.
   
Süveg K, Putora P M, Joerger M, Iseli T, Fischer G F, Ammann K, Glatzer M. Radiotherapy for thymic epithelial tumours: a review. Transl Lung Cancer Res 2021; 10:2088-2100.
   
Le Pechoux C, Faivre-Finn C, Ramella S, McDonald F, Manapov F, Putora P M, Slotman B, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Van Houtte P, Nestle U. ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer. Radiother Oncol 2020; 152:89-95.
   
Glatzer M, Horber D, Montemurro M, Winterhalder R, Inauen R, Berger M, Pestalozzi B, Pederiva S, Pless M, Putora P M. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20 (2020):686-690.
   
Achard V, Aebersold D M, Allal A S, Andratschke N, Baumert B G, Beer K T, Betz M, Breuneval T, Bodis S, De Bari B, Förster R, Franzetti-Pellanda A, Guckenberger M, Herrmann E, Huck C, Khanfir K, Matzinger O, Peguret N, Pesce G, Putora P M, Reuter C, Richetti A, Vees H, Vrieling C, Zaugg K, Zimmermann F, Zwahlen D R, Tsoutsou P, Zilli T. A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives. Radiother Oncol 2020; 150:1-3.
   
Treffers T, Putora P M. Emotions as Social Information in Shared Decision-Making in Oncology. Oncology 2020; 98:430-437.
   
Glatzer M, Horber D, Montemurro M, Winterhalder R, Inauen R, Berger M D, Pestalozzi B, Pederiva S, Pless M, Putora P M. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20:686-690.
   
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda M A, Klepetko W, Lacourt A, McElnay P, Maskell N A, Mutti L, Pairon J C, Van Schil P, Van Meerbeeck J P, Waller D, Weder W, Cardillo G, Putora P M. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J 2020; 55:.
   
Opitz I, Scherpereel A, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D A, Galateau-Salle F, Greillier L, Hoda M A, Klepetko W, Lacourt A, McElnay P, Maskell N A, Mutti L, Pairon J C, Van Schil P, Van Meerbeeck J P, Waller D, Weder W, Putora P M, Cardillo G. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2020; 58:1-24.
   
Iseli T, Berghmans T, Glatzer M, Rittmeyer A, Massard G, Durieux V, Buchsbaum T, Putora P M. Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy. ERJ Open Res 2020; 6:.
   
Troost E G C, Nestle U, Putora P M, Bussink J. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol 2020; 147:227-228.
   
Glatzer M, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost E G C, Dahele M R, Slotman B J, Ramella S, Pöttgen C, Peeters S T H, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Putora P M. Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise. Radiother Oncol 2020; 150:26-29.
   
Putora P M, Baudis M, Beadle B M, El Naqa I, Giordano F A, Nicolay N H. Oncology Informatics: Status Quo and Outlook. Oncology 2020; 98:329-331.
   
Viktorin-Baier P, Putora P M, Schmid H P, Plasswilm L, Schwab C, Thoeni A, Hochreiter W, Prikler L, Suter S, Stucki P, Müntener M, Blick N, Schiefer H, Guesewell S, Zürn K, Engeler D S. Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry. BJU Int 2020; 125:827-835.
   
Schmid H P, Viktorin P, Putora P M, Schiefer J, Schwab C, Plasswilm L, Engeler D S. Langzeitresultate des prospektiven Schweizer Registers LDR-Brachytherapie des lokalisierten Prostatakarzinoms. German Medical Science, www.egms.de 2020;.
   
Iseli T, Fischer G, Panje C, Glatzer M, Hundsberger T, Rothermundt C, Schmidt B, Sirén C, Plasswilm L, Putora P M. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
   
De Bruycker A, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte F, Papachristofilou A, Scorsetti M, Shelan M, Siva S, Ameye F, Guckenberger M, Heikkilä R, Putora P M, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ost P. PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. BMC Cancer 2020; 20:406.
   
Glatzer M, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost E G C, Slotman B J, Ramella S, Pöttgen C, Peeters S T H, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Süveg K, Putora P M. Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine. Radiother Oncol 2020; 154:269-273.
   
Den Hollander J, Broglie M A, Henke G, Siano M, Putora P M, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery). Front Oncol 2019; 9:1125.
   
Steffen T, Putora P M, Hübner M, Gloor B, Lehmann K, Kettelhack C, Adamina M, Peterli R, Schmidt J, Ris F, Glatzer M. Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey. Clin Colorectal Cancer 2019; 18:e335-e342.
   
Broglie M A, Dulguerov P, Henke G, Siano M, Putora P M, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers). Front Oncol 2019; 9:1128.
   
Garelli E, Rittmeyer A, Putora P M, Glatzer M, Dressel R, Andreas S. Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy 2019; 11:1445-1461.
   
Siano M, Dulguerov P, Broglie M A, Henke G, Putora P M, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology). Front Oncol 2019; 9:1127.
   
Hundsberger T, Schoser B, Leupold D, Rösler K M, Putora P M. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. J Neurol 2019; 266:2010-2017.
   
Putora P M. Decision Making in Oncology. JCO Clin Cancer Inform 2019; 3:1-2.
   
Elicin O, Putora P M, Siano M, Broglie M A, Simon C, Zwahlen D, Huber G, Ballerini G, Beffa L, Giger R, Rothschild S, Negri S V, Dulguerov P, Henke G. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology). Front Oncol 2019; 9:1126.
   
Panje C, Zilli T, Pra A D, Arnold W, Brouwer K, Garcia Schüler H I, Gomez S, Herrera F, Khanfir K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D, Putora P M. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice. Radiat Oncol 2019; 14:177.
   
Putora P M, Glatzer M, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, De Marinis F, Dziadziuszko R, Felip E, Faivre-Finn C, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O'Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Slotman B, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, De Ruysscher D. Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019; 133:163-166.
   
Putora P M, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, De Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, Brien M O, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman B J. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019; 135:74-77.
   
Scheithauer W, Putora P M, Grünberger B, Eisterer W, Wöll E, Prager G, Schaberl-Moser R, Greil R, Glatzer M. Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine. Therap Adv Gastroenterol 2019; 12:1756284819877635.
   
Schlachter M, Raidou R, Muren L, Preim B, Putora P M, Bühler K. State-of-the-Art Report: Visual Computing in Radiation Therapy Planning. Computer Graphics Forum 2019;753-779.
   
Panje C, Putora P M, Hundsberger T, Hottinger A F, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
   
Putora P M, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, De Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O' Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman B J. Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]. Radiother Oncol 2019; 141:332.
   
Putora P M, De Ruysscher D, Glatzer M, Widder J, Van Houtte P, Troost E G C, Slotman B J, Ramella S, Pöttgen C, Peeters S, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Faivre-Finn C. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. Radiother Oncol 2019; 145:45-48.
   
Maas O, Forrer F, Maas M, Panje C, Blautzik J, Brühlmeier M, Engel-Bicik I, Giovanella L, Haldemann A, Kamel M E, Kneifel S, Rottenburger C, Schaefer N, Walter M A, Weidner S, Putora P M. Variations in radioiodine ablation: decision-making after total thyroidectomy. Eur J Nucl Med Mol Imaging 2019;.
   
Glatzer M, Panje C, Sirén C, Cihoric N, Putora P M. Decision Making Criteria in Oncology. Oncology 2018;1-9.
   
Putora P M. Electronic Patient-Reported Outcomes: A New Standard of Care?. Oncology 2018;1-2.
   
Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber R M, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora P M, Samarzija M, Scherpereel A, Schlesser M, Sculier J P, Skrickova J, Sotto-Mayor R, Strand T E, Van Schil P, Blum T G. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries. BMC Cancer 2018; 18:1144.
   
Glatzer M, Panje C, Siren C, Cihoric N, Putora P M. Decision Making Criteria in Oncology. Oncology 2018; Sep 18:1-9:.
   
Glatzer M, Putora P M. Der Einsatz der Radiotherapie beim kleinzelligen Lungenkarzinom: Update 2018. Schweizer Zeitschrift für Onkologie (SZO) 2018; 1:11-13.
   
Süveg K, Putora P M, Berghmans T, Glatzer M, Kovac V, Cihoric N. Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry. Lung Cancer 2018; 124:12-18.
   
Zumstein V, Betschart P, Abt D, Schmid H P, Panje C, Putora P M. Surgical management of urolithiasis - a systematic analysis of available guidelines. BMC Urology 2018;.
   
Radovic M, Kanesvaran R, Rittmeyer A, Früh M, Minervini F, Glatzer M, Putora P M. Multidisciplinary treatment of lung cancer in older patients: A review. J Geriatr Oncol 2018; 10:405-410.
   
Putora P M, Markman M. Introduction to the New Section "Oncology and Informatics". Oncology 2018;1.
   
Nestle U, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Slotman B, Ramella S, Faivre-Finn C, McDonald F, Manapov F, Putora P M, LePéchoux C, Van Houtte P. ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. Radiother Oncol 2018; 127:1-5.
   
Panje C, Glatzer M, Sirén C, Plasswilm L, Putora P M. Treatment Options in Oncology. JCO Clin Cancer Inform 2018; 2:1-10.
   
Rich A L, Baldwin D R, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen N C, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert A P, Milroy R, Mutti L, Paesmans M, Peake M D, Putora P M, De Ruysscher D, Sculier J P, Schepereel A, Subotic D, Van Schil P, Blum T G. ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe. Eur Respir J 2018;.
   
Putora P M, Schmid H P. Oligometastasiertes Prostatakarzinom. Aktuelle Entwicklungen in der Urologie und Radioonkologie. Leading Opinions Hämatol Onkol 2017; 13:58-60.
   
Panje C, Glatzer M, Von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora P M. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Med Res Methodol 2017; 17:123.
   
Ghadjar P, Hayoz S, Bernhard J, Zwahlen D R, Stein J, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller A C, Putora P M, Papachristofilou A, Schär C, Dal Pra A, Biaggi Rudolf C, Wust P, Aebersold D M, Thalmann G N, Swiss Group For Clinical Cancer Research (SAKK) . Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10. Radiother Oncol 2017;.
   
Glatzer M, Schmid S, Radovic M, Früh M, Putora P M. The role of radiation therapy in the management of small cell lung cancer. Breathe (Sheff) 2017; 13:e87-e94.
   
Ghadjar P, Hayoz S, Genitsch V, Zwahlen D R, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller A C, Putora P M, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi N C, Reuter C, Bodis S, Khanfir K, Budach V, Aebersold D M, Thalmann G N, Swiss Group For Clinical Cancer Research (SAKK) . Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer. BJU Int 2017; 120:E45-E51.
   
Rothermundt C, Fischer G, Bauer S, Blay J Y, Grünwald V, Italiano A, Kasper B, Kollár A, Lindner L H, Miah A, Sleijfer S, Stacchiotti S, Putora P M. Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey. Oncologist 2017;.
   
Warschkow R, Gueller U, Cerny T, Schmied B, Plasswilm L, Putora P M. Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiother Oncol 2017; 123:139-146.
   
Dal Pra A, Panje C, Zilli T, Arnold W, Brouwer K, Garcia H, Glatzer M, Gomez S, Herrera F, Kaouthar K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D R, Engeler D, Putora P M. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice. Strahlenther Onkol 2017; 194:9-16.
   
Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora P M. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J 2017; 50:.
   
Müller J, Putora P M, Schneider T, Zeisel C, Brutsche M, Bartz-Batliner M, Markus A, Kick J. Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions. Interact Cardiovasc Thorac Surg 2016; 23:345-350.
   
Putora P M, Engeler D S, Haile S, Graf N, Buchauer K, Schmid H P, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2016; 192:182-9.
   
Bertolini R, Meyenberger C, Putora P M, Albrecht F, Broglie M, Stöckli S, Sulz M. Endoscopic dilation of complete oesophageal obstructions with a combined antegrade-retrograde rendezvous technique. World J Gastroenterol 2016; 22:2366-72.
   
Hundsberger T, Hottinger A F, Roelcke U, Roth P, Migliorini D, Dietrich P Y, Conen K, Pesce G, Hermann E, Pica A, Gross M W, Brügge D, Plasswilm L, Weller M, Putora P M. Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. J Neurooncol 2016; 126:175-183.
   
Glatzer M, Elicin O, Ramella S, Nestle U, Putora P M. Radio(chemo)therapy in locally advanced nonsmall cell lung cancer. Eur Respir Rev 2016; 25:65-70.
   
Glatzer M, Putora P M, Plasswilm L. Radioimmuntherapie – die neue Strategie im Kampf gegen Krebs? Wirkprinzipien, Therapiekonzepte und (prä-)klinische Studiendaten. SZO 2016;.
   
Rothermundt C, Von Rappard J, Eisen T, Escudier B, Grünwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B, Schmidinger M, Sternberg C N, Putora P M. Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms. World J Urol 2016;.
   
Putora P M, Szentesi K, Glatzer M, Rodriguez R, Müller J, Baty F, Früh M. SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer. Oncol Res Treat 2016; 39:681-686.
   
Panje C, Panje T, Putora P M, Kim S K, Haile S, Aebersold D M, Plasswilm L. Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiat Oncol 2015; 10:47.
   
Rothermundt C, Bailey A, Cerbone L, Eisen T, Escudier B, Gillessen S, Grünwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B, Schmidinger M, Sternberg C, Putora P M. Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma-Analysis Using Diagnostic Nodes. Oncologist 2015; 20:1028-35.
   
Putora P M, Engeler D S, Haile S R, Graf N, Buchauer K, Schmid H P, Plasswilm L. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlenther Onkol 2015; 192:182-9.
   
Plasswilm L, Schmid H P, Schwab C, Putora P M. (Neo-) Adjuvante endokrine Therapie des lokoregionär begrenzten Prostatakarzinoms. J Urol Urogynäkol 2015; 22:10-5.
   
Panje C, Dal Pra A, Zilli T, R Zwahlen D, Papachristofilou A, Herrera F G, Matzinger O, Plasswilm L, Putora P M. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice. Strahlenther Onkol 2015; 191:778-86.
   
Engeler D S, Schwab C, Thöni A F, Hochreiter W, Prikler L, Suter S, Stucki P, Schiefer J, Plasswilm L, Schmid H P, Putora P M. PSA bounce after (125)I-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-791.
   
Putora P M, Ess S, Panje C, Hundsberger T, Van Leyen K, Plasswilm L, Früh M. Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC). Clin Exp Metastasis 2015; 32:143-9.
   
Engeler D S, Putora P M, Schmid H P, Aebersold D. Permanente interstitielle Brachytherapie mit Jod-125. info@onkologie 2015; 5:13-5.
   
Glatzer M, Putora P M. Radiochemotherapie beim lokal fortgeschrittenen NSCLC - Update 2015. SZO 2015; 4:18-22.
   
Engeler D S, Schwab C, Thöni A, Hochreiter W, Prikler L, Suter S, Stucki P, Schiefer J, Plasswilm L, Schmid H P, Putora P M. PSA bounce after 125J-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol 2015; 191:787-91.
   
Hundsberger T, Tonder M, Hottinger A, Brügge D, Roelcke U, Putora P M, Stupp R, Weller M. Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. J Neurooncol 2014; 118:321-328.
   
Putora P M, Panje C, Papachristofilou A, Pra A, Hundsberger T, Plasswilm L. Objective consensus from decision trees. Radiat Oncol 2014; 9:270.
   
Blum T G, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen N C G, Hubbard R, Huber R M, Jakobsen E, Jovanovic D, Konsoulova A, Kollmeier J, Massard G, McPhelim J, Meert A P, Milroy R, Paesmans M, Peake M, Putora P M, Scherpereel A, Schönfeld N, Sitter H, Skaug K, Spiro S, Strand T E, Taright S, Thomas M, Van Schil P E, Vansteenkiste J F, Wiewrodt R, Sculier J P. The European initiative for quality management in lung cancer care. Eur Respir J 2014; 43:1254-77.
   
Putora P M, Oldenburg J. The Kafkaesque process of cancer diagnosis. J Clin Oncol 2014; 32:1087-8.
   
Putora P M, Früh M, Müller J. FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology 2013; 18:734-5.
   
Baty F, Putora P M, Isenring B, Blum T, Brutsche M. Comorbidities and Burden of COPD: A Population Based Case-Control Study. PLoS ONE 2013; 8:e63285.
   
Putora P M, Oldenburg J. Swarm-based medicine. J Med Internet Res 2013; 15:e207.
   
Putora P M, Müller J, Borovicka J, Plasswilm L, Schmidt F. Relevance of incidental colorectal FDG-PET/CT-enhanced lesions. Onkologie 2013; 36:200-4.
   
Hundsberger T, Brügge D, Putora P M, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
   
Putora P M, Schmücking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiation Oncology 2012; 2012:208.
   
Preusser S, Putora P M, Plasswilm L, Schmid H P. Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options. Der Urologe 2012; 51:27-31.
   
Schallegger K, Preusser S, Putora P M. Lokale palliative Therapieoptionen beim Prostatakarzinom: Interdisziplinäres Vorgehen bei Schmerzen, infravesikaler Obstruktion, Blutung und therapiebedingten Nebenwirkungen. Schweizerische Zeitschrift für Onkologie 2012; 2012:33-36.
   
Cerny T, Rothermundt C, Putora P M. Palliative Systemtherapie des metastasierten Weichteil-Sarkoms. info@onkologie 2012; 2012:6-9.
   
Putora P M, Horstkemper R, Plasswilm L. Palliative Radiotherapie beim NSCLC: Indikationen und Verfahren. Schweizerische Zeitschrift für Onkologie 2012; 1:12-16.
   
Putora P M, Schneider T, Rodriguez R, Früh M. Targeted therapy in non-small cell lung cancer. Breathe 2012; 8:206-215.
   
 
page 1 of 2